| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/19/2004 | US20040162245 Use of ribose to treat fibromyalgia |
| 08/19/2004 | US20040162243 Compositions of S-nitrosothiols and methods of use |
| 08/19/2004 | US20040162235 Forming a complex of polyampholyte and siRNA; and, delivering the complex into a cell |
| 08/19/2004 | US20040161840 Bax-Responsive genes for drug target identification in yeast and fungi |
| 08/19/2004 | US20040161814 for drug screening enzyme inhibitors using gel chromatography; bioassays; gene therapy; genetic engineering |
| 08/19/2004 | US20040161758 Identifying/screening ruminant foods and products for presence of viral agents associated with spongiform encephalopathy; immunoassays |
| 08/19/2004 | US20040161745 Nucleotide sequences coding glucuronidase for identifying modulators for treatment of inflammation; wound healing agents and tissue repair |
| 08/19/2004 | US20040161526 Mixing cyclodextrins with food; antidiabetic agents; metabolism disease; obesity; hypotensive agents |
| 08/19/2004 | US20040161484 Mixture of polyglycerol fatty ester, glycerol fatty ester with vegetable oil |
| 08/19/2004 | US20040161481 Analgesics; in situ administering by injection or infiltration; concurretn with nsaid; side effect reduction- |
| 08/19/2004 | US20040161480 Antiinflammatory agents; repair of damage tissue; mixture of metabolites and plant extracts; synergistic mixture of chondroitin sulfate and glucosamine |
| 08/19/2004 | US20040161477 Plant extracts such as gallotannins; prevent reproduction of virus |
| 08/19/2004 | US20040161476 Aqueous solution; bladder and urogenital disorders |
| 08/19/2004 | US20040161475 Anticancer, antitumor agents; ssynergistic mixtures with retinoic acid; olid tumors |
| 08/19/2004 | US20040161466 Chemoembolisation |
| 08/19/2004 | US20040161462 Sustained release; hypoglycemic agents; synergistic mixture |
| 08/19/2004 | US20040161461 Extended release pharmaceutical tablet of metformin |
| 08/19/2004 | US20040161460 Enteric coated formulation for bisphosphonic acids and salts thereof |
| 08/19/2004 | US20040161457 Method of administering a compound to multi-drug resistant cells |
| 08/19/2004 | US20040161456 Delivery and activation through liposome incorporation of diaminocyclohexane platinum(II) complexes |
| 08/19/2004 | US20040161455 Method for treating multi-drug resistant tumors |
| 08/19/2004 | US20040161451 Soft filament occlusive device delivery system |
| 08/19/2004 | US20040161441 Containing permethrin, imidacloprid and n-methylpyrrolidone; killing ticks and fleas; skin friendly, low toxicity; storage stability |
| 08/19/2004 | US20040161436 Skin treatment composition and method |
| 08/19/2004 | US20040161434 Nonaqueous liquid; acceptable taste; diluting in aqueous diluent for oral administration |
| 08/19/2004 | US20040161430 Dye-azide compounds for dual phototherapy |
| 08/19/2004 | US20040161428 Such as transferrin-doxorubicin conjugate linked by gluteraldehyde; inexpensive, effective |
| 08/19/2004 | US20040161426 Use of IL-6 antagonists in combination with steroids to enhance apoptosis |
| 08/19/2004 | US20040161422 Nutritional compositions comprising probiotics |
| 08/19/2004 | US20040161415 Inducted heat shock proteins in activated lymphocytes |
| 08/19/2004 | US20040161407 Medicinal compositions |
| 08/19/2004 | US20040161405 Guanidinium transport reagents and conjugates |
| 08/19/2004 | US20040161398 Compositions and methods for targeting cancer cells |
| 08/19/2004 | US20040161393 Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders |
| 08/19/2004 | US20040161392 Using salicylic acid derivative; side effect reduction |
| 08/19/2004 | US20040161386 Pharmaceutical compositions based on anticholinergic and dopamine agonists |
| 08/19/2004 | US20040161385 Delivery of beta-blockers through an inhalation route |
| 08/19/2004 | US20040161382 Oral drug delivery system |
| 08/19/2004 | US20040160876 Method for determining a tilt angle of an optical pickup head |
| 08/19/2004 | DE20220917U1 Zusammensetzungen zur Verhinderung des Missbrauchs von Opioiden Compositions to prevent the misuse of opioids |
| 08/19/2004 | DE10305318A1 Treating bacterial infections of respiratory organs comprises local administration of ciprofloxacin, enrofloxacin or their sparingly soluble salts in solid form |
| 08/19/2004 | DE10305212A1 Verwendung der sgk-Genfamilie zur Diagnose und zur Therapie von Katarakt und Glaukom Use of the sgk gene family for the diagnosis and treatment of cataract and glaucoma |
| 08/19/2004 | DE10304950A1 Herstellung von Tetrahydrochinolinbenzofuranen Production of Tetrahydrochinolinbenzofuranen |
| 08/19/2004 | DE10237722A1 Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase Indole or benzimidazole derivatives for the modulation of IkappaB kinase |
| 08/19/2004 | DE10237442B4 Hochverzweigte, niedrig substituierte Stärkeprodukte Highly branched, low-substituted starch products |
| 08/19/2004 | DE10142663B4 C2-Disubstituierte Indan-1-ol-Systeme C2-Disubstituted indan-1-ol systems |
| 08/19/2004 | CA2552137A1 Prevention of surgical adhesions using selective cox-2 inhibitors |
| 08/19/2004 | CA2516942A1 Use of quinazoline derivatives or other compounds for inhibiting dihydrofolate reduxtase; screening assay for the identification of novel therapeutics and their cellular targets |
| 08/19/2004 | CA2515717A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| 08/19/2004 | CA2515644A1 Oligomeric compounds for the modulation of ras expression |
| 08/19/2004 | CA2515623A1 Oligomeric compounds for the modulation of survivin expression |
| 08/19/2004 | CA2515339A1 Use of a novel polymorphism in the hsgk1 gene in the diagnosis of hypertonia and use of the sgk gene family in the diagnosis and therapy of the long qt syndrome |
| 08/19/2004 | CA2515331A1 Polymer guanidine derivatives as a cytostatic medicament |
| 08/19/2004 | CA2515311A1 Antibacterial agents |
| 08/19/2004 | CA2515294A1 Therapeutic agents for diabetes |
| 08/19/2004 | CA2515290A1 Oils enriched with diacylglycerols and phytosterol esters for use in the reduction of cholesterol and triglycerides |
| 08/19/2004 | CA2515269A1 Oxazolidinone derivatives n-substituted by a bicyclic ring, for use as antibacterial agents |
| 08/19/2004 | CA2515266A1 Use of dipyridamole or mopidamole for treatment and prevention of mmp-9-dependent disorders |
| 08/19/2004 | CA2515235A1 Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists |
| 08/19/2004 | CA2515174A1 Breast cancer resistance protein (bcrp) inhibitor |
| 08/19/2004 | CA2515160A1 Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis |
| 08/19/2004 | CA2515135A1 Breast cancer-resistant protein inhibitor |
| 08/19/2004 | CA2515119A1 Pyrazole derivative |
| 08/19/2004 | CA2515102A1 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof |
| 08/19/2004 | CA2515095A1 Regimen of administration for nelfinavir |
| 08/19/2004 | CA2515090A1 Process for producing levetiracetam |
| 08/19/2004 | CA2515070A1 Novel compounds |
| 08/19/2004 | CA2515048A1 Methods for treatment of ibs and nud |
| 08/19/2004 | CA2515025A1 Sugar-free oral transmucosal solid dosage forms and uses thereof |
| 08/19/2004 | CA2515000A1 Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors |
| 08/19/2004 | CA2514968A1 Pharmaceutical compositions comprising an active agent and chitosan for sustained drug release or mucoadhesion |
| 08/19/2004 | CA2514966A1 Antiglucocorticoids for the treatment of postpartum psychosis |
| 08/19/2004 | CA2514952A1 Chitosan foodstuff |
| 08/19/2004 | CA2514942A1 Methods and compositions for the treatment of parkinson's disease and other a-synucleinopathies |
| 08/19/2004 | CA2514841A1 Cell-killing molecules and methods of use thereof |
| 08/19/2004 | CA2514703A1 Use of the sgk gene family for diagnosis and therapy of cataracts and glaucoma |
| 08/19/2004 | CA2514641A1 Methods for modulating an inflammatory response |
| 08/19/2004 | CA2514563A1 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 08/19/2004 | CA2514334A1 Novel antiherpes drug combinations |
| 08/19/2004 | CA2514301A1 Therapeutic use of acylglycerols and the nitrogen- and sulphur-containing analogues thereof |
| 08/19/2004 | CA2514028A1 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds |
| 08/19/2004 | CA2513915A1 New arylpiperazinyl compounds |
| 08/19/2004 | CA2513824A1 Saturated quinoxaline derivatives and their use as metabotropic glutamate receptor ligands |
| 08/19/2004 | CA2513731A1 Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases |
| 08/19/2004 | CA2513409A1 Pyrazolo`1,5-a!`1,3,5!triazine derivatives as cannabinoid receptor ligands |
| 08/19/2004 | CA2513402A1 Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof |
| 08/19/2004 | CA2513401A1 N-monoacylated o-phenylenediamines as anti -cancer agents |
| 08/19/2004 | CA2513260A1 Oral compositions of fenretinide having increased bioavailability and methods of using the same |
| 08/19/2004 | CA2513109A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 08/19/2004 | CA2512275A1 Cosmetic composition based on cirsimarin |
| 08/19/2004 | CA2510275A1 Pharmaceutical composition of 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5h-2,3-benzodiazepine and uses therof |
| 08/19/2004 | CA2506619A1 Cell lines and host nucleic acid sequences related to infectious disease |
| 08/18/2004 | EP1447445A1 PROBE SOLUTIN COMPOSITIONS, REACTIVE CHIP USING THE SAME AND PROCESS FOR THE PRODUCTION THEREOF |
| 08/18/2004 | EP1447407A1 Adenosine derivatives |
| 08/18/2004 | EP1447402A1 Quinoline compound |
| 08/18/2004 | EP1447401A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 08/18/2004 | EP1447400A1 Bicyclic compound |
| 08/18/2004 | EP1447399A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses" |
| 08/18/2004 | EP1447398A1 Retroviral protease inhibitors |
| 08/18/2004 | EP1447397A1 Polyfunctional sulfonamides and sulfonates and process for preparing them |